IGC to be Featured in Feb. 10 Radius Research Investor Webinar
February 08, 2023 08:30 ET
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Feb. 08, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces that Ram Mukunda, CEO, and Claudia...
Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
February 07, 2023 09:00 ET
|
Next Move Strategy Consulting
New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 billion in 2021, and is projected to...
PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New Drug Application of KETARX™ (Ketamine) On-Body Pump System
February 07, 2023 07:59 ET
|
PharmaTher Holdings Ltd.
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in advancing specialty ketamine pharmaceuticals, today...
Drug Discovery Services Market is expected to grow at 15.6 percent reaching 53.58 Bn by 2029, Regional Analysis, Competitive Landscape and Regional Analysis
February 03, 2023 05:26 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, a leading Healthcare research, and consultancy firm have a business intelligence report on the emerging “Drug Discovery Services...
Global Allergy Diagnostic Market Anticipated to Generate a Revenue of $16,714.2 Million and Rise at a CAGR of 13.2% during the Estimated Timeframe 2022-2031 [250-Pages] | Exclusive by Research Dive
January 12, 2023 09:00 ET
|
Research Dive
New York, USA, Jan. 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global allergy diagnostic market is envisioned to garner $16,714.2 million in revenue and grow...
Drug Repurposing Market 2023 Will Revenue to Cross reach US$ 30920 million by 2028 Research by Business Opportunities, Top Companies report covers, Market-specific challenges, consumption by Regional data
January 10, 2023 06:12 ET
|
Proficient Market Insights
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Drug Repurposing Market" research report focus on overall information that can help to take decisions on current market situation. Drug Repurposing Market...
Lantern Pharma to Participate at the RHK Capital Disruptive Growth Conference on December 5 at 12:00 p.m. ET
December 02, 2022 08:00 ET
|
Lantern Pharma Inc.
DALLAS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence...
Societal CDMO Reports Third Quarter 2022 Financial Results
November 09, 2022 16:05 ET
|
Societal CDMO, Inc.
Recorded Q3 Revenue of $21.6 Million, a 19% Increase Compared to Prior Year Period Entered into Real Estate Sales and Purchase Agreement Expected to Generate Proceeds of More than $9 Million Signed...
Societal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022
November 02, 2022 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Awarded Two New CDMO Service Contracts Focused on Supporting Ongoing Clinical Development Programs for Novel Therapeutic Candidates
September 07, 2022 07:00 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...